Association of tumor-informed circulating tumor DNA dynamics with radiologic disease assessment in a single-center real-world sarcoma cohort
Sarcomas are rare and heterogeneous malignant tumors for which reliable blood-based biomarkers for longitudinal disease monitoring remain limited. Circulating tumor DNA (ctDNA) has emerged as a minimally invasive biomarker in several solid tumors, but its clinical utility in sarcoma remains incompletely defined because...